Amicus Therapeutics, Inc. carries a market capitalization of 5.27B, placing it among publicly traded companies globally.
| Market Cap | 5.27B |
| Enterprise Value | N/A |
Amicus Therapeutics, Inc.'s stock has gained approximately 174.75884% over the past 52 weeks. The 50-day moving average sits at 13.10, while the 200-day moving average is 12.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | 174.75884% |
| 50-Day Moving Average | 13.10 |
| 200-Day Moving Average | 12.19 |
| Average Volume (20 Days) | N/A |